I suspect this announcement will create some panic selling. Hopefully it's short lived as I don't read it as remotely material or one that dims IMM's future prospects.
Ann: Ulcerative Colitis Phase II Study of GSK2831781 Discontinued, page-4
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
26.8¢ |
Change
0.008(2.88%) |
Mkt cap ! $394.3M | |||
| Open | High | Low | Value | Volume |
| 26.0¢ | 27.0¢ | 26.0¢ | $556.6K | 2.079M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 353931 | 26.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 27.0¢ | 332707 | 19 |
View Market Depth
| Last trade - 11.55am 18/07/2025 (20 minute delay) ? |
| IMM (ASX) Chart |